In this study, we identified TLR4 as the key receptor mediating BGN-induced activation of the Erk and NF-κB pathways in ESCC, providing novel mechanistic insight into BGN’s role in this malignancy. This evidence concerns the gene BGN and esophageal squamous cell carcinoma.